产品中实际含有多少
暂无产品标示该成分含量。
含该成分的产品中,8 款将其列在 1% 线之前,3 款列在之后(通常不超过 1%)。
含有此成分的产品
已确认 11 款中的 11 款 · 按含量充足程度排序
Elizabeth ArdenElizabeth Arden Retinol + HPR Ceramide Rapid Skin-Renewing Water Cream
Elizabeth ArdenElizabeth Arden Retinol + HPR Ceramide Rapid Skin Renewing Eye Cream
medicubemedicube Deep Vita A Retinol Serum
MEDIPEELRetinal NMN Bounce Shot Eye Cream
MEDIPEELMEDIPEEL Retinal NMN Bounce Shot Eye Cream 15ml
MuradMurad Rapid Relief Acne Spot Treatment
COSMECHEFBaekdanggo Dark Spot Sun Stick
CNP LaboratoryDerma Answer Tension Angle-fit Ampule
EucerinEucerin UltraSENSITIVE Repair Serum 30ml
Shua IrehMoisture Cooling Sun Mist
LAVIENLAVIEN Collagen Ice Gel Pad 4g x 2 x 5 Sheets
定义
美国FDA 物质登记 · UNII K0H1405S9C · 登记名称 4-TERT-BUTYLCYCLOHEXANOL · 混合物
化妆品中的作用
为产品增添香味PERFUMING登记为香料组成物质(并非表示其增香)FRAGRANCE
安全与法规参考
未列入韩国有毒物质 GHS 分类 · 现有化学物质
详细资料——标示名称、识别编号、物性、试验记录、文献
官方标示名称和定义
日本化妆品工业联合会标示名称 4-t-ブチルシクロヘキサノール: 本品は、次の化学式で表される有機化合物である。
来源: 日本化妆品工业联合会标示名称
别名和识别信息
4-T-BUTYLCYCLOHEXANOLINCI4-t-부틸사이클로헥산올韩国标示名称(食药处标准名)Cyclohexanol, 4-(1,1-dimethylethyl)-同义名4-t-ブチルシクロヘキサノール日本标示名称
- CAS No.化学物质登记号
- 21862-63-5
- CAS No.化学物质登记号
- 98-52-2
- EC No.欧盟化学品目录编号
- 202-676-4
- DTXSID美国EPA化学品编号
- DTXSID5026623
- DTXCID美国EPA化合物编号
- DTXCID606623
- IUPAC
- 4-tert-Butylcyclohexan-1-ol
- 分子式
- C10H20O
- 分子量
- 156.269 g/mol
实测物性
- 性状
- Dry Powder, CBI, Liquid · White powder, [Sigma-Aldrich MSDS]
- 熔点/凝固点
- 60~67 ℃
- 初沸点和沸程
- 218.6 ℃
- 闪点
- 105 ℃
- 易燃性(固体、气体)
- 易燃
- 蒸气压
- 0.1 hPa
- 溶解度
- 0.0001 ㎎/ℓ
- 蒸气密度
- 5.39
- 比重
- 0.867 (@ 21.94 ℃)
- 正辛醇/水分配系数(Kow)
- 1680
- 分子量
- 156.27
这是对物质本身测得的数值。韩国安全保健公团(KOSHA)的资料仅供编写和审核安全数据表参考,并非原料商品的规格。
来源: PubChem · 韩国安全保健公团 安全数据表
产品实际使用的用途
刺激与致敏试验记录
记录有皮肤试验 7 项、眼部试验 2 项。
归类为低7 项
试验结论基本一致(100%)。 这是对原料本身的试验记录,与成品中所含浓度下的刺激性不同。
查看全部 9 项试验
- Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: as mentioned below according to - SkinIrr2
Skin Irritation · QSAR Predicted - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: as mentioned below - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: OECD Guideline 402 (Acute Dermal Toxicity) according to - Not likely to be sensitizing
skin sensitisation · Screening · according to other guideline: as mentioned below - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) adopted in May 1981 - Ambiguous
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) adopted in 1981 according to - Severe Irritation
eye irritation: in vivo · Screening · other guideline: as mentioned below according to - Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) adopted in 2012 according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) adopted in May 1981 according to
来源: 美国EPA CompTox
相关文献
- The Long-Term Efficacy of a Moisturizer Containing 4-T-Butylcyclohexanol and Licochalcone a as Adjunctive Therapy for Facial Seborrheic Dermatitis · 2023
- 286 A novel soothing complex for sensitive skin treatment: 4-t-butylcyclohexanol, seed extracts of tephrosia purpurea and schisandra sphenanthera · 2024
- Clinical studies in Chinese subjects investigating the tolerance and soothing efficacy of a cream and balm containing 4‐t‐butylcyclohexanol on the sensitivity of facial skin · 2022
- Efficacy of a skin care cream with TRPV1 inhibitor 4‐t‐butylcyclohexanol in the topical therapy of perioral dermatitis · 2019
- Effects of dextran sulfate, 4-t-butylcyclohexanol, pongamia oil and hesperidin methyl chalcone on inflammatory and vascular responses implicated in rosacea · 2018